Blissway vs Moderna

Side-by-side comparison of AI visibility scores, market position, and capabilities

Moderna leads in AI visibility (90 vs 77)
Blissway logo

Blissway

LeaderHealthcare

General

Computer vision fleet safety platform with real-time driver behavior monitoring and in-cab coaching; YC W20-backed competing with Samsara and Lytx for fleet accident reduction and insurance cost savings.

AI VisibilityBeta
Overall Score
B77
Category Rank
#67 of 596
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
71
Perplexity
72
Gemini
81

About

Blissway is a Tel Aviv-based road safety technology company using computer vision and AI to monitor and analyze driver behavior in real-time — providing fleets, trucking companies, and insurance carriers with dashcam-based driver risk scoring, real-time coaching alerts, and safety analytics that reduce accident rates and insurance costs. Backed by Y Combinator (W20) with $2.63-9.3 million raised across multiple rounds including a 2023 round supported by Maniv Mobility, Measured Ventures, and others, Blissway operates in the fleet safety and telematics market.

Full profile
Moderna logo

Moderna

LeaderHealthcare Tech

Enterprise

mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.

AI VisibilityBeta
Overall Score
A90
Category Rank
#2 of 596
AI Consensus
83%
Trend
stable
Per Platform
ChatGPT
92
Perplexity
93
Gemini
89

About

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.

Full profile

AI Visibility Head-to-Head

77
Overall Score
90
#67
Category Rank
#2
70
AI Consensus
83
stable
Trend
stable
71
ChatGPT
92
72
Perplexity
93
81
Gemini
89
74
Claude
96
81
Grok
95

Key Details

Category
General
Enterprise
Tier
Leader
Leader
Entity Type
company
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.